Viking Therapeutics off 5% following CEO stock sale
MR1805/iStock via Getty Images
- Viking Therapeutics (NASDAQ:VKTX) is down ~5% Tuesday following the disclosure that CEO Brian Lian sold shares.
- Per a Monday evening SEC filing, Lian sold 45K shares at a price of $22.45 each. That comes out to ~$1M.
- He still owns ~2.2M shares.
- The filing said that the transaction was conducted pursuant to a trading plan adopted by Lian.